Amphastar Pharmaceuticals (AMPH) PT Lowered to $21 at Piper Sandler
May 11, 2026 6:46 AM
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $25.00) while maintaining a Neutral rating.
